Chargement en cours...
Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery
PURPOSE: Trastuzumab is effective in early and advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, few studies have reported the effect of trastuzumab on ipsilateral breast tumor recurrence (IBTR), whose incidence is higher in the HER2-positive subtype than in o...
Enregistré dans:
| Publié dans: | J Breast Cancer |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Breast Cancer Society
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250103/ https://ncbi.nlm.nih.gov/pubmed/34190441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e33 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|